William Mack & Associates’s Medline Inc MDLN Stock Holding History

William Mack & Associates’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.63K	Buy	+47	New	+$1.72K	﹤0.01%	592

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

William Mack & Associates's MDLN Position: Q3 2026 in Review

William Mack & Associates opened a new position in Medline Inc (MDLN) in Q3 2026: 47 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #592 among its holdings.

315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

William Mack & Associates held 47 shares of Medline Inc worth $1.63K as of Q3 2026.
Medline Inc was a new William Mack & Associates position in Q3 2026.
Medline Inc made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #592 holding.
315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.